India’s biotechnology sector has immense growth potential and is already a key player in the Asia-Pacific region, ranking third in terms of the number of biotech companies. Approximately 40% of these companies operate in the biopharma segment, while the rest specialize in agri-biotech, bioinformatics, industrial biotechnology, and bioservices. These firms provide cutting-edge services in drug discovery, validation, genomics, proteomics, and related fields.

In 2007-08, the Indian biotech market was valued at US$ 2.8 billion, representing 2% of the global market share. With a favorable economic environment, it was projected to reach US$ 5 billion by 2010.